Trxade Group Inc.’s (NASDAQ: MEDS) E-Commerce Platform Targeting Independent Pharmacy Market of Over $78 Billion a Year
Company boasts significant first-mover advantage in proprietary web-based e-commerce platform segment Revenue growth driven by increases in the number of registered users and acquisition of Pharmacy Currently adding 100+ pharmacies per month to its online purchasing platform Trxade seeking FDA approval for antibody rapid test that can be used for COVID-19 patients Trxade Group Inc. (NASDAQ: MEDS) is an integrated drug delivery, procurement, and health care platform that offers health care buyers and sellers of pharmaceuticals increased profit margins. The company has developed a proprietary web-based e-commerce platform (S2P – Supplier to Pharmacy) designed to help pharmacies reduce expenses by…